Diabetogenic polypeptide from human pituitaries similar to that excreted by proteinuric diabetic patients
dc.contributor.author | Louis, Lawrence H. | en_US |
dc.contributor.author | Conn, Jerome W. | en_US |
dc.date.accessioned | 2006-04-17T16:53:04Z | |
dc.date.available | 2006-04-17T16:53:04Z | |
dc.date.issued | 1972-01 | en_US |
dc.identifier.citation | Louis, Lawrence H., Conn, Jerome W. (1972/01)."Diabetogenic polypeptide from human pituitaries similar to that excreted by proteinuric diabetic patients." Metabolism 21(1): 1-9. <http://hdl.handle.net/2027.42/34180> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WN4-4C4FJX7-FJ/2/02a725a39968e659fe5864b4c215ccf2 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/34180 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=5008013&dopt=citation | en_US |
dc.description.abstract | A polypeptide exhibiting diabetogenic and antiinsulin properties has been isolated from human pituitary glands by a procedure slightly modified from that with which a similar polypeptide was previously isolated from the adenohypophysis of cattle, sheep and pigs. The isoelectric point of the compound is approximately pH 4.1 which is the same as that of the compound isolated from the adenohypophysis of the other three species and from urine of patients with lipoatrophic diabetes and proteinuric diabetics without lipoatrophy. Administration of 1 mg polypeptide per kilogram of body weight to dogs resulted in significant intolerance to glucose and resistance to exogenous insulin 10 and 34 hours after injection. Comparison of glucose tolerance tests in the same animals discloses that the diabetogenic potency of the substance from human pituitaries is much greater than that of human growth hormone or ovine prolactin. The molecular weight of the substance as determined by the dodecyl sulfate-polyacrylamide gel electrophoresis method is 20,600. A modified procedure for the isolation and purification of the polypeptide has been outlined. | en_US |
dc.format.extent | 670713 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Diabetogenic polypeptide from human pituitaries similar to that excreted by proteinuric diabetic patients | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Metabolism Research Unit, University of Michigan Medical School, Ann Arbor, Mich., USA; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan Medical School, Ann Arbor, Mich., USA | en_US |
dc.contributor.affiliationum | Metabolism Research Unit, University of Michigan Medical School, Ann Arbor, Mich., USA; Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan Medical School, Ann Arbor, Mich., USA | en_US |
dc.identifier.pmid | 5008013 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/34180/1/0000469.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0026-0495(72)90014-5 | en_US |
dc.identifier.source | Metabolism | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.